ClinicalTrials.govpublic full text
A Phase 3 Study of Siltuximab or Placebo in Combination With Velcade and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma
multiple myeloma, dexamethasone, siltuximab, cnto 328, il-6, monoclonal antibody, relapsed or refractory, velcade, bortezomib, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 903274
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.